Latest News about FBRX
Recent news which mentions FBRX
12 Health Care Stocks Moving In Thursday's Intraday Session
September 26, 2024
From Benzinga
FBRX Stock Earnings: Forte Biosciences Misses EPS for Q2 2024
August 14, 2024
Tickers
FBRX
From InvestorPlace
Tickers
FBRX
From InvestorPlace
Tickers
FBRX
From InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
December 15, 2023
From Benzinga
Research Frontiers And 3 Other Stocks Under $1 Insiders Are Buying
December 13, 2023
From Benzinga
RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying
December 11, 2023
From Benzinga
Insiders Buying Vintage Wine Estates And 3 Other Stocks Under $1
November 24, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 20, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
November 17, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
August 04, 2023
From Benzinga
Earnings Scheduled For May 26, 2023
May 26, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 04, 2022
From Benzinga
Boeing, PriceSmart And 80 Biggest Movers From Yesterday
July 13, 2022
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
May 17, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 08, 2022
From Benzinga
From InvestorPlace
52 Biggest Movers From Friday
January 31, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 16, 2021
From Benzinga
A Look Into Healthcare Sector Value Stocks
November 01, 2021
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
October 25, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
20 Stocks Moving in Wednesday's Pre-Market Session
September 22, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.